Atlas Trials

Study of Tumor Treating Fields With Hypofractionated Chemoradiotherapy in Newly Diagnosed Glioblastoma

Clinical trial NCT04474353 · COMPLETED

Trial details

NCT number
NCT04474353
Sponsor
Stanford University
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
GlioblastomaNewly Diagnosed Glioblastoma
Start date
2021-05-21
Primary completion
2024-11-14
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.